With the newly reported A3 and CC7 antibodies CA IX was shown to be expressed heterogeneously throughout the majority of the studied tumours, with exception of renal cell carcinomas in which all cancer cells express the antigen as a consequence of a mutated VHL gene (Rathmell and Chen, 2008) (Figure 5). This evidence concerns the gene VHL and cancer.